Health Care: Drugs

Immunoclin Corp (IMCL: OTC)

$5.5 n/a | n/a%
09/16/14 - 12:02 PM ET
Company Income Statement
Jan 2014 Feb 2013 Feb 2012
Sales 0.00 0.00 0.00
Cost of Sales 0.00 0.00 0.00
Gross Operating Profit 0.00 0.00 0.00
Selling, General, and Administrative Expenses 12.68M 39.84K 84.70K
Research & Development 98.28K 0.00 0.00
Operating Income before D & A (EBITDA) -12.77M -39.84K -84.70K
Depreciation & Amortization 208.14K 0.00 0.00
Interest Income 0.00 0.00 0.00
Other Income - Net 2.24K 39.50K 0.00
Special Income / Charges 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) -12.98M -338.00 -84.70K
Interest Expense 89.00 0.00 0.00
Pre-Tax Income -12.98M -338.00 -84.70K
Income Taxes 0.00 0.00 0.00
Minority Interest 0.00 0.00 0.00
Net Income From Continuing Operations -12.98M -338.00 -84.70K
Net Income From Discontinued Operations 0.00 0.00 0.00
Net Income From Total Operations -12.98M -338.00 -84.70K
Extraordinary Income/Losses 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00
Total Net Income -12.98M -338.00 -84.70K
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-12.98M -338.00 -84.70K
Preferred Dividends
Net Income Available To Common -12.98M -338.00 -84.70K
Basic EPS from Continuing Ops. -1.20 0.00 -0.02
Basic EPS from Discontinued Ops. 0.00 0.00 0.00
Basic EPS from Total Operations -1.20 0.00 -0.02
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) -0.01 0.00 0.00
Basic EPS, Total -1.21 0.00 -0.02
Basic Normalized Net Income/Share -1.20 0.00 -0.02
EPS fr Continuing Ops. -1.20 0.00 -0.02
EPS fr Discontinued Ops 0.00 0.00 0.00
EPS fr Total Ops. -1.20 0.00 -0.02
EPS fr Extraord. Inc. 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00
EPS fr Other Gains (L) -0.01 0.00 0.00
EPS, Total -1.21 0.00 -0.02
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-1.20 0.00 -0.02
Dividends Paid per Share 0.00 0.00 0.00

Portfolios with IMCL

Latest IMCL Headlines from TheStreet

More Financial News for IMCL

Press Releases for IMCL

See All Press Releases

Partner Headlines for IMCL

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter